Home / Beyond CBD / COVID medicines
Home / Beyond CBD / COVID medicines
BioPharm’s pharmaceutical manufacturing facility, while built for the patented process of CBD and other cannabinoid manufacture, has the flexibility to produce many other medicines and organic molecules. In emergency situations we can produce bulk anti-viral medicines locally.
At the outbreak of COVID pandemic, India, China and even United Kingdom began acting under laws preventing the export of certain critical medicines.
BioPharm have ability to source and manufacture certain critical medicines if required in response to COVID or future health pandemics.
Our COVID response R&D focus is on the development of trauma medicines.
Powered by WhatsApp Chat